Analysts Lift 12-Month Targets for Six US-Listed Stocks

what happened

TradingView reported that the average 12-month price target for Park Hotels & Resorts Inc., based on estimates from 16 analysts, increased from $15.78 to $15.91. Forecasts range from $13 to $20 per share. Compared with the Oct. 9 closing price, the revised target implies approximately 5% potential upside. The consensus rating is “Hold” among 18 covering analysts, including 6 Buys, 10 Holds and 2 Sells.

According to TradingView, Salesforce, Inc.’s average target rose from $282.78 to $285.24 based on estimates from 51 analysts. Forecasts span $165 to $400 per share, while the updated target implies approximately 24% upside from the Oct. 9 close. The “Buy” consensus remains in place across 60 analysts, with 42 Buys, 17 Holds and 1 Sell.

Newsmetry API reported that the target for Charles River Laboratories International, Inc. increased from $322.2 to $324.87. The 15-analyst forecast range is $295 to $357, implying approximately 8% potential upside. The “Buy” consensus remains unchanged among 21 analysts: 15 Buys, 4 Holds and 2 Sells. For First Tracks Biotherapeutics, Inc., the target rose from $71.25 to $72.08, with forecasts ranging from $57 to $100 and implied upside of approximately 126%; all 12 analysts rate the stock Buy.

Mattel, Inc.’s average target moved from $17.92 to $18.08, with 12 analysts forecasting $11 to $28 per share and approximately 8% upside. The “Buy” consensus remains across 18 analysts: 12 Buys, 4 Holds and 2 Sells. Mirum Pharmaceuticals, Inc.’s target increased from $148.86 to $151.64; estimates from 14 analysts range from $118 to $200, implying approximately 76% upside. All 14 analysts maintain a Buy rating.

why it matters

The revisions indicate changes in analyst expectations across companies from several industries. Price targets and consensus ratings represent analyst views and do not guarantee future stock performance.

instruments